A U.S. appeals court affirms decision barring Alvogen from marketing generic version of Bausch's Xifaxan until 2029.
Loss of confidence in Saint Mary's leadership | SaltWire - A U.S. appeals court on Thursday affirmed a decision for Bausch Health that barred rival drugmaker Alvogen from marketing a proposed generic version of Bausch's diarrhea treatment Xifaxan until 2029.
Bausch has said the litigation could affect its plans to spin off its eye-care business Bausch + Lomb. Analysts at Jefferies said on Thursday that the decision removes a"key barrier" for the spinoff. Xifaxan is approved to treat traveler's diarrhea and irritable bowel syndrome and can be used to prevent the liver-related brain disorder hepatic encephalopathy .
Norwich asked the U.S. Court of Appeals for the Federal Circuit to reverse the district court's decision to block its generic based on the infringement, while Salix appealed the decision to invalidate its other patents.
Bausch Health Alvogen Generic Drug Xifaxan Patents Infringement FDA Spinoff
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
No. 12 Grand Canyon sends No. 5 Saint Mary's home with first round upset victoryTyon Grant-Foster scored 22 points, and Grand Canyon joined the list of schools to win an NCAA Tournament game as the 12th-seeded Antelopes knocked off No. 5 seed Saint Mary’s 75-66 on Friday night.
Read more »
Faculty union supports non-confidence motion in Saint Mary’s University in HalifaxThe Saint Mary’s University’s administration issued a statement today saying the school’s financial challenges are no different than those facing the post-secondary sector across Canada
Read more »
Cape Breton’s Aimee O’Neill named Saint Mary’s Huskies’ unsung heroExplore stories from Atlantic Canada.
Read more »
Cape Breton’s Amiee O’Neill named Saint Mary’s Huskies’ unsung heroExplore stories from Atlantic Canada.
Read more »
Saint John closing part of Saint Patrick Street Pedway for redevelopmentExplore stories from Atlantic Canada.
Read more »